Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
PaperCitations, authors & open-access status
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 308 citations, 2021 year and green oa status.
308
Citations
2021
Year
green
OA Status